

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 6.38988501 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.00658438 |
| 3 | intestinal absorption (GO:0050892) | 5.94376556 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.50632126 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.50632126 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.29930712 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.29930712 |
| 8 | phospholipid efflux (GO:0033700) | 5.08756361 |
| 9 | high-density lipoprotein particle remodeling (GO:0034375) | 4.89434237 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.83734795 |
| 11 | regulation of cholesterol esterification (GO:0010872) | 4.79819065 |
| 12 | regulation of triglyceride catabolic process (GO:0010896) | 4.78570855 |
| 13 | urea cycle (GO:0000050) | 4.70147941 |
| 14 | urea metabolic process (GO:0019627) | 4.70147941 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.63595015 |
| 16 | negative regulation of sterol transport (GO:0032372) | 4.56984511 |
| 17 | negative regulation of cholesterol transport (GO:0032375) | 4.56984511 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.55659541 |
| 19 | reverse cholesterol transport (GO:0043691) | 4.54807430 |
| 20 | bile acid and bile salt transport (GO:0015721) | 4.45101588 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44468194 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37239667 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.36022969 |
| 24 | cholesterol efflux (GO:0033344) | 4.31453717 |
| 25 | kynurenine metabolic process (GO:0070189) | 4.30521233 |
| 26 | flavonoid metabolic process (GO:0009812) | 4.30237337 |
| 27 | drug catabolic process (GO:0042737) | 4.29665208 |
| 28 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28738382 |
| 29 | negative regulation of cell killing (GO:0031342) | 4.28738382 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.26752378 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 4.26151216 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 4.26151216 |
| 33 | tryptophan catabolic process (GO:0006569) | 4.26151216 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 4.23359277 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19433046 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.18914017 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.18914017 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18914017 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 4.18373344 |
| 40 | homocysteine metabolic process (GO:0050667) | 4.18209301 |
| 41 | cysteine metabolic process (GO:0006534) | 4.16886985 |
| 42 | regulation of bile acid biosynthetic process (GO:0070857) | 4.10755368 |
| 43 | bile acid biosynthetic process (GO:0006699) | 4.08315827 |
| 44 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.06028383 |
| 45 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.06028383 |
| 46 | cellular ketone body metabolic process (GO:0046950) | 4.05164831 |
| 47 | tryptophan metabolic process (GO:0006568) | 4.04447942 |
| 48 | bile acid metabolic process (GO:0008206) | 4.02966220 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.01994151 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.01994151 |
| 51 | protein-lipid complex assembly (GO:0065005) | 3.83089452 |
| 52 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.76853519 |
| 53 | lipoprotein metabolic process (GO:0042157) | 3.72301900 |
| 54 | cholesterol homeostasis (GO:0042632) | 3.70349394 |
| 55 | sterol homeostasis (GO:0055092) | 3.66414570 |
| 56 | phospholipid homeostasis (GO:0055091) | 3.64965998 |
| 57 | protein carboxylation (GO:0018214) | 3.64928569 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.64928569 |
| 59 | angiotensin maturation (GO:0002003) | 3.62563111 |
| 60 | complement activation, alternative pathway (GO:0006957) | 3.62430341 |
| 61 | glyoxylate metabolic process (GO:0046487) | 3.56791025 |
| 62 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.55354191 |
| 63 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.55354191 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.54423123 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 3.53345201 |
| 66 | epoxygenase P450 pathway (GO:0019373) | 3.51826771 |
| 67 | cellular glucuronidation (GO:0052695) | 3.49560904 |
| 68 | detection of bacterium (GO:0016045) | 3.46416707 |
| 69 | ketone body metabolic process (GO:1902224) | 3.46305535 |
| 70 | drug transmembrane transport (GO:0006855) | 3.45155809 |
| 71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.44727021 |
| 72 | regulation of fibrinolysis (GO:0051917) | 3.44389245 |
| 73 | regulation of protein activation cascade (GO:2000257) | 3.44004363 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.43856017 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.42550444 |
| 76 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.41349545 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 3.41045406 |
| 78 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.40207472 |
| 79 | detection of other organism (GO:0098543) | 3.40041204 |
| 80 | plasma lipoprotein particle organization (GO:0071827) | 3.38903249 |
| 81 | lysine catabolic process (GO:0006554) | 3.38056503 |
| 82 | lysine metabolic process (GO:0006553) | 3.38056503 |
| 83 | glutamate metabolic process (GO:0006536) | 3.36639896 |
| 84 | cholesterol transport (GO:0030301) | 3.35334817 |
| 85 | sterol transport (GO:0015918) | 3.35334817 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 3.32989458 |
| 87 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.32984084 |
| 88 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.29131900 |
| 89 | serine family amino acid catabolic process (GO:0009071) | 3.27145227 |
| 90 | tyrosine metabolic process (GO:0006570) | 3.26881775 |
| 91 | amino-acid betaine metabolic process (GO:0006577) | 3.26761245 |
| 92 | exogenous drug catabolic process (GO:0042738) | 3.26364481 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.26298042 |
| 94 | NADH metabolic process (GO:0006734) | 3.24570061 |
| 95 | drug metabolic process (GO:0017144) | 3.23878966 |
| 96 | protein-lipid complex subunit organization (GO:0071825) | 3.23542931 |
| 97 | regulation of complement activation (GO:0030449) | 3.19299159 |
| 98 | alpha-amino acid catabolic process (GO:1901606) | 3.19038881 |
| 99 | surfactant homeostasis (GO:0043129) | 3.15242662 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.11320857 |
| 101 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.09747891 |
| 102 | ethanol oxidation (GO:0006069) | 3.09142939 |
| 103 | cellular amino acid catabolic process (GO:0009063) | 3.08790214 |
| 104 | lipid homeostasis (GO:0055088) | 3.08280765 |
| 105 | glucuronate metabolic process (GO:0019585) | 3.04417512 |
| 106 | uronic acid metabolic process (GO:0006063) | 3.04417512 |
| 107 | indolalkylamine metabolic process (GO:0006586) | 3.04016755 |
| 108 | hormone catabolic process (GO:0042447) | 3.02721913 |
| 109 | diacylglycerol metabolic process (GO:0046339) | 3.02163593 |
| 110 | short-chain fatty acid metabolic process (GO:0046459) | 3.01705501 |
| 111 | transcytosis (GO:0045056) | 3.01627033 |
| 112 | benzene-containing compound metabolic process (GO:0042537) | 3.01297486 |
| 113 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.01293996 |
| 114 | negative regulation of lipase activity (GO:0060192) | 2.99984529 |
| 115 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.95680014 |
| 116 | drug transport (GO:0015893) | 2.94956485 |
| 117 | coenzyme catabolic process (GO:0009109) | 2.93544059 |
| 118 | ethanol metabolic process (GO:0006067) | 2.93112514 |
| 119 | cellular response to reactive nitrogen species (GO:1902170) | 2.92830279 |
| 120 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.91783702 |
| 121 | phospholipid scrambling (GO:0017121) | 2.91310285 |
| 122 | response to laminar fluid shear stress (GO:0034616) | 2.86744892 |
| 123 | renal system process involved in regulation of blood volume (GO:0001977) | 2.84421949 |
| 124 | thymic T cell selection (GO:0045061) | 2.83780355 |
| 125 | signal complex assembly (GO:0007172) | 2.81195480 |
| 126 | regulation of cellular extravasation (GO:0002691) | 2.80968740 |
| 127 | T cell selection (GO:0045058) | 2.78857062 |
| 128 | mannose metabolic process (GO:0006013) | 2.77783477 |
| 129 | regulation of guanylate cyclase activity (GO:0031282) | 2.77076582 |
| 130 | lipoprotein transport (GO:0042953) | 2.76906515 |
| 131 | regulation of ARF protein signal transduction (GO:0032012) | 2.75532512 |
| 132 | positive thymic T cell selection (GO:0045059) | 2.74282629 |
| 133 | peptide catabolic process (GO:0043171) | 2.73388489 |
| 134 | regulation of extracellular matrix disassembly (GO:0010715) | 2.70240781 |
| 135 | negative thymic T cell selection (GO:0045060) | 2.66563969 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63466094 |
| 137 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61480943 |
| 138 | modulation by symbiont of host defense response (GO:0052031) | 2.61480943 |
| 139 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61480943 |
| 140 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61480943 |
| 141 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61480943 |
| 142 | modulation by symbiont of host immune response (GO:0052553) | 2.61480943 |
| 143 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.59497650 |
| 144 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58254945 |
| 145 | negative T cell selection (GO:0043383) | 2.57497318 |
| 146 | macrophage activation involved in immune response (GO:0002281) | 2.55087603 |
| 147 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.48030745 |
| 148 | cellular response to nitric oxide (GO:0071732) | 2.47772575 |
| 149 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.46485670 |
| 150 | multicellular organismal water homeostasis (GO:0050891) | 2.45965155 |
| 151 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.45042103 |
| 152 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.43518264 |
| 153 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.43300896 |
| 154 | regulation of T cell tolerance induction (GO:0002664) | 2.42928071 |
| 155 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42651721 |
| 156 | dendritic cell chemotaxis (GO:0002407) | 2.42481220 |
| 157 | positive regulation of Rap GTPase activity (GO:0032854) | 2.42429746 |
| 158 | neutrophil activation involved in immune response (GO:0002283) | 2.40959777 |
| 159 | detection of external biotic stimulus (GO:0098581) | 2.40871061 |
| 160 | positive T cell selection (GO:0043368) | 2.34804390 |
| 161 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.30922773 |
| 162 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.30276688 |
| 163 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.29884723 |
| 164 | embryonic process involved in female pregnancy (GO:0060136) | 2.29044097 |
| 165 | leukocyte aggregation (GO:0070486) | 2.28988404 |
| 166 | regulation of tolerance induction (GO:0002643) | 2.28250527 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.27541052 |
| 168 | response to nitric oxide (GO:0071731) | 2.25661613 |
| 169 | histone H3-K36 demethylation (GO:0070544) | 2.25399083 |
| 170 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.24399888 |
| 171 | chemical homeostasis within a tissue (GO:0048875) | 2.23912817 |
| 172 | fructose metabolic process (GO:0006000) | 2.23047662 |
| 173 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.22749801 |
| 174 | endocrine process (GO:0050886) | 2.22749801 |
| 175 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.22749801 |
| 176 | interferon-gamma secretion (GO:0072643) | 2.22593371 |
| 177 | desmosome organization (GO:0002934) | 2.21401445 |
| 178 | regulation of leukocyte degranulation (GO:0043300) | 2.20625295 |
| 179 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.18205637 |
| 180 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.17217473 |
| 181 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.16278821 |
| 182 | actin filament polymerization (GO:0030041) | 2.15677311 |
| 183 | leukotriene metabolic process (GO:0006691) | 2.15446253 |
| 184 | dendritic cell migration (GO:0036336) | 2.14988955 |
| 185 | response to muramyl dipeptide (GO:0032495) | 2.11907854 |
| 186 | regulation of regulated secretory pathway (GO:1903305) | 2.11175002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.31017797 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.19597111 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.61604614 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.14589917 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.38129227 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.96832175 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.34771011 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.27017998 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.06997085 |
| 10 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.45860720 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.27308897 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.24601507 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24338984 |
| 14 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.22753485 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.20154339 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.17561481 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.97708148 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89029211 |
| 19 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81401167 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76908532 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74291144 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74177827 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.74061646 |
| 24 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.71882546 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69784651 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68456043 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.66804868 |
| 28 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.65362359 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63097139 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62513936 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.54755574 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.54295144 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53072319 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48402858 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.46856412 |
| 36 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46343957 |
| 37 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.44448564 |
| 38 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43738059 |
| 39 | MYC_22102868_ChIP-Seq_BL_Human | 1.42968687 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42014522 |
| 41 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40759059 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.39524773 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38712253 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.38704779 |
| 45 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36815123 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36333987 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.32549804 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32389095 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31465287 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.28976962 |
| 51 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.27976394 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26797349 |
| 53 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24070261 |
| 54 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23686888 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23586572 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22977536 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22701735 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.22691778 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.21046948 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20980985 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.19697455 |
| 62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19031836 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18498859 |
| 64 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18023354 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16231241 |
| 66 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15649752 |
| 67 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15375601 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13625155 |
| 69 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13275031 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13111420 |
| 71 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11657153 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11403788 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11399269 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10134027 |
| 75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.09447865 |
| 76 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08752423 |
| 77 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.07877999 |
| 78 | P68_20966046_ChIP-Seq_HELA_Human | 1.07667436 |
| 79 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07529767 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.06441311 |
| 81 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06293974 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03269563 |
| 83 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02956259 |
| 84 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02313339 |
| 85 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02139324 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02137168 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01176817 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 1.00358123 |
| 89 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00304237 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00204763 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99209133 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.99037915 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98069665 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96880118 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94494013 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94342667 |
| 97 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93918815 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93766039 |
| 99 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92010020 |
| 100 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91314514 |
| 101 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87337189 |
| 102 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85747740 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.82898519 |
| 104 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82148202 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81857250 |
| 106 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.81772558 |
| 107 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.79539739 |
| 108 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78910002 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77937533 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.77843269 |
| 111 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76721517 |
| 112 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76284759 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75481607 |
| 114 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.73814327 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.73432161 |
| 116 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.72902601 |
| 117 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.72698217 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72687911 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.71846796 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.70614441 |
| 121 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70463214 |
| 122 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69606543 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69527330 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69427814 |
| 125 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69334838 |
| 126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.68337863 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.65995790 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.65198308 |
| 129 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.64863277 |
| 130 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.64281255 |
| 131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.64196646 |
| 132 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.62863748 |
| 133 | ATF3_27146783_Chip-Seq_COLON_Human | 0.62691801 |
| 134 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.62074088 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.61353424 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.60801838 |
| 137 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.60432356 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.59800830 |
| 139 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.58710941 |
| 140 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.58384925 |
| 141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57255904 |
| 142 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.57148744 |
| 143 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.56930267 |
| 144 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.55823944 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.55809490 |
| 146 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.54938776 |
| 147 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.54918901 |
| 148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.54918901 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.54713577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.57175881 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.61113143 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.39294595 |
| 4 | MP0005365_abnormal_bile_salt | 5.15721885 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.34371049 |
| 6 | MP0001666_abnormal_nutrient_absorption | 4.16393702 |
| 7 | MP0003252_abnormal_bile_duct | 3.95044482 |
| 8 | MP0009840_abnormal_foam_cell | 3.36237756 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.24173452 |
| 10 | MP0003724_increased_susceptibility_to | 3.07918572 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.91960472 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.70399394 |
| 13 | MP0003436_decreased_susceptibility_to | 2.44331878 |
| 14 | MP0004782_abnormal_surfactant_physiolog | 2.19676129 |
| 15 | MP0005083_abnormal_biliary_tract | 2.14169191 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.11098535 |
| 17 | MP0002822_catalepsy | 2.08551601 |
| 18 | MP0005332_abnormal_amino_acid | 2.08545300 |
| 19 | MP0003195_calcinosis | 2.06926264 |
| 20 | MP0003868_abnormal_feces_composition | 1.98109238 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.96638565 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.95123436 |
| 23 | MP0000609_abnormal_liver_physiology | 1.94813345 |
| 24 | MP0003303_peritoneal_inflammation | 1.93334787 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.93215439 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.88321237 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.82640157 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.78662254 |
| 29 | MP0005025_abnormal_response_to | 1.66709608 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.62226535 |
| 31 | MP0005409_darkened_coat_color | 1.61083423 |
| 32 | MP0003866_abnormal_defecation | 1.58226157 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.58008570 |
| 34 | MP0004043_abnormal_pH_regulation | 1.56860012 |
| 35 | MP0005387_immune_system_phenotype | 1.53421978 |
| 36 | MP0001790_abnormal_immune_system | 1.53421978 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.51929231 |
| 38 | MP0001800_abnormal_humoral_immune | 1.49308144 |
| 39 | MP0002009_preneoplasia | 1.44985477 |
| 40 | MP0002419_abnormal_innate_immunity | 1.43646136 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.40336122 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.39944840 |
| 43 | MP0009780_abnormal_chondrocyte_physiolo | 1.37978913 |
| 44 | MP0009785_altered_susceptibility_to | 1.36438398 |
| 45 | MP0008260_abnormal_autophagy | 1.33802641 |
| 46 | MP0003705_abnormal_hypodermis_morpholog | 1.29352987 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.29244943 |
| 48 | MP0001851_eye_inflammation | 1.29064248 |
| 49 | MP0003828_pulmonary_edema | 1.27656276 |
| 50 | MP0002723_abnormal_immune_serum | 1.27123414 |
| 51 | MP0000462_abnormal_digestive_system | 1.26595504 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.25293747 |
| 53 | MP0001819_abnormal_immune_cell | 1.25255778 |
| 54 | MP0002420_abnormal_adaptive_immunity | 1.24780710 |
| 55 | MP0001873_stomach_inflammation | 1.21628555 |
| 56 | MP0003045_fibrosis | 1.21191501 |
| 57 | MP0008004_abnormal_stomach_pH | 1.21168463 |
| 58 | MP0002254_reproductive_system_inflammat | 1.21094229 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20380402 |
| 60 | MP0009379_abnormal_foot_pigmentation | 1.20215941 |
| 61 | MP0000490_abnormal_crypts_of | 1.19433852 |
| 62 | MP0002452_abnormal_antigen_presenting | 1.18046235 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.16600163 |
| 64 | MP0006082_CNS_inflammation | 1.14684100 |
| 65 | MP0001764_abnormal_homeostasis | 1.14552888 |
| 66 | MP0005636_abnormal_mineral_homeostasis | 1.14454148 |
| 67 | MP0005058_abnormal_lysosome_morphology | 1.13624325 |
| 68 | MP0001501_abnormal_sleep_pattern | 1.13453734 |
| 69 | MP0002078_abnormal_glucose_homeostasis | 1.13272652 |
| 70 | MP0000685_abnormal_immune_system | 1.12393033 |
| 71 | MP0001765_abnormal_ion_homeostasis | 1.11918263 |
| 72 | MP0005671_abnormal_response_to | 1.11483785 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.11432737 |
| 74 | MP0003690_abnormal_glial_cell | 1.10700707 |
| 75 | MP0005448_abnormal_energy_balance | 1.09141917 |
| 76 | MP0001958_emphysema | 1.07103831 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.07002790 |
| 78 | MP0005501_abnormal_skin_physiology | 1.03160274 |
| 79 | MP0002693_abnormal_pancreas_physiology | 1.02812987 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.01556219 |
| 81 | MP0004510_myositis | 1.01257138 |
| 82 | MP0004381_abnormal_hair_follicle | 1.00902492 |
| 83 | MP0002148_abnormal_hypersensitivity_rea | 1.00651200 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 1.00424762 |
| 85 | MP0005084_abnormal_gallbladder_morpholo | 0.99519119 |
| 86 | MP0002098_abnormal_vibrissa_morphology | 0.99456523 |
| 87 | MP0004858_abnormal_nervous_system | 0.99081984 |
| 88 | MP0001663_abnormal_digestive_system | 0.98346265 |
| 89 | MP0000858_altered_metastatic_potential | 0.97651773 |
| 90 | MP0002006_tumorigenesis | 0.97492002 |
| 91 | MP0002405_respiratory_system_inflammati | 0.97190959 |
| 92 | MP0003091_abnormal_cell_migration | 0.97133141 |
| 93 | MP0005451_abnormal_body_composition | 0.95830107 |
| 94 | MP0002132_abnormal_respiratory_system | 0.95782722 |
| 95 | MP0005381_digestive/alimentary_phenotyp | 0.95358866 |
| 96 | MP0005076_abnormal_cell_differentiation | 0.95308417 |
| 97 | MP0000249_abnormal_blood_vessel | 0.94921537 |
| 98 | MP0003283_abnormal_digestive_organ | 0.93616539 |
| 99 | MP0001944_abnormal_pancreas_morphology | 0.93160751 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.92179582 |
| 101 | MP0000604_amyloidosis | 0.91206410 |
| 102 | MP0009642_abnormal_blood_homeostasis | 0.90653761 |
| 103 | MP0000716_abnormal_immune_system | 0.89313739 |
| 104 | MP0001756_abnormal_urination | 0.87481949 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.87257858 |
| 106 | MP0004883_abnormal_blood_vessel | 0.87130454 |
| 107 | MP0009697_abnormal_copulation | 0.85138504 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.84646838 |
| 109 | MP0000598_abnormal_liver_morphology | 0.82501370 |
| 110 | MP0001664_abnormal_digestion | 0.76843960 |
| 111 | MP0005535_abnormal_body_temperature | 0.75910467 |
| 112 | MP0000538_abnormal_urinary_bladder | 0.75690027 |
| 113 | MP0008469_abnormal_protein_level | 0.75229479 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.74702410 |
| 115 | MP0004947_skin_inflammation | 0.74155410 |
| 116 | MP0002796_impaired_skin_barrier | 0.70948037 |
| 117 | MP0005334_abnormal_fat_pad | 0.70608233 |
| 118 | MP0003953_abnormal_hormone_level | 0.70337238 |
| 119 | MP0005166_decreased_susceptibility_to | 0.65789060 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.65486366 |
| 121 | MP0005310_abnormal_salivary_gland | 0.65319986 |
| 122 | MP0009764_decreased_sensitivity_to | 0.65308593 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.64185901 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.63117080 |
| 125 | MP0002971_abnormal_brown_adipose | 0.62806331 |
| 126 | MP0008872_abnormal_physiological_respon | 0.61511606 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.60758202 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.59716650 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.59436696 |
| 130 | MP0001881_abnormal_mammary_gland | 0.58279731 |
| 131 | MP0005167_abnormal_blood-brain_barrier | 0.57540345 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.55118931 |
| 133 | MP0009763_increased_sensitivity_to | 0.54689232 |
| 134 | MP0005266_abnormal_metabolism | 0.53956579 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.53529065 |
| 136 | MP0003075_altered_response_to | 0.53182895 |
| 137 | MP0005376_homeostasis/metabolism_phenot | 0.52277597 |
| 138 | MP0003329_amyloid_beta_deposits | 0.52094451 |
| 139 | MP0002166_altered_tumor_susceptibility | 0.51822871 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.51018377 |
| 141 | MP0004185_abnormal_adipocyte_glucose | 0.50743882 |
| 142 | MP0003879_abnormal_hair_cell | 0.49756229 |
| 143 | MP0005408_hypopigmentation | 0.48971336 |
| 144 | MP0002837_dystrophic_cardiac_calcinosis | 0.48893365 |
| 145 | MP0005670_abnormal_white_adipose | 0.48805243 |
| 146 | MP0003453_abnormal_keratinocyte_physiol | 0.48487999 |
| 147 | MP0002877_abnormal_melanocyte_morpholog | 0.47469778 |
| 148 | MP0004130_abnormal_muscle_cell | 0.46343452 |
| 149 | MP0005647_abnormal_sex_gland | 0.45137384 |
| 150 | MP0008873_increased_physiological_sensi | 0.44740779 |
| 151 | MP0000678_abnormal_parathyroid_gland | 0.44093158 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.44008560 |
| 153 | MP0002928_abnormal_bile_duct | 0.43286697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 6.08367002 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.96618360 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.81381723 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.45579976 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.44006404 |
| 6 | Xanthomatosis (HP:0000991) | 5.20476751 |
| 7 | Deep venous thrombosis (HP:0002625) | 5.02337877 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 4.64291352 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57561441 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 4.53640161 |
| 11 | Hypoglycemic coma (HP:0001325) | 4.40286045 |
| 12 | Fat malabsorption (HP:0002630) | 4.29348914 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.16341359 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 3.86908913 |
| 15 | Ketosis (HP:0001946) | 3.84219964 |
| 16 | Interstitial pulmonary disease (HP:0006530) | 3.83659676 |
| 17 | Ketoacidosis (HP:0001993) | 3.76878912 |
| 18 | Acanthocytosis (HP:0001927) | 3.74362488 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.72279835 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.70624368 |
| 21 | Epidermoid cyst (HP:0200040) | 3.67535426 |
| 22 | Complement deficiency (HP:0004431) | 3.64984070 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.64323682 |
| 24 | Hypoglycemic seizures (HP:0002173) | 3.60119492 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58725313 |
| 26 | Hyperammonemia (HP:0001987) | 3.53874537 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.51181538 |
| 28 | Ileus (HP:0002595) | 3.43974696 |
| 29 | Malnutrition (HP:0004395) | 3.42169618 |
| 30 | Hyperglycinuria (HP:0003108) | 3.40628961 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.34633920 |
| 32 | Recurrent abscess formation (HP:0002722) | 3.22545575 |
| 33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.21751231 |
| 34 | Symptomatic seizures (HP:0011145) | 3.21206634 |
| 35 | Decreased circulating renin level (HP:0003351) | 3.14536826 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.02987356 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.01906394 |
| 38 | Late onset (HP:0003584) | 3.01285662 |
| 39 | Abnormality of glycine metabolism (HP:0010895) | 2.99717555 |
| 40 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.99717555 |
| 41 | Hemorrhage of the eye (HP:0011885) | 2.99403097 |
| 42 | Hyperbilirubinemia (HP:0002904) | 2.97450448 |
| 43 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.95206903 |
| 44 | Joint hemorrhage (HP:0005261) | 2.83600386 |
| 45 | Flat acetabular roof (HP:0003180) | 2.82482412 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.82109980 |
| 47 | Abnormality of macrophages (HP:0004311) | 2.79376778 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.79213235 |
| 49 | Gingivitis (HP:0000230) | 2.78930627 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.78604036 |
| 51 | Hyperglycemia (HP:0003074) | 2.77687364 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76536695 |
| 53 | Growth hormone excess (HP:0000845) | 2.76407979 |
| 54 | Hyperglycinemia (HP:0002154) | 2.76010100 |
| 55 | Increased IgE level (HP:0003212) | 2.73051083 |
| 56 | Abdominal distention (HP:0003270) | 2.70174842 |
| 57 | Thin bony cortex (HP:0002753) | 2.69897545 |
| 58 | Myositis (HP:0100614) | 2.69498345 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.63648299 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.63648299 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.61707165 |
| 62 | Sensorimotor neuropathy (HP:0007141) | 2.60958988 |
| 63 | Abnormality of the fingertips (HP:0001211) | 2.60404107 |
| 64 | Abnormality of complement system (HP:0005339) | 2.58651566 |
| 65 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.58536434 |
| 66 | Abnormality of methionine metabolism (HP:0010901) | 2.56514711 |
| 67 | Metabolic acidosis (HP:0001942) | 2.53755328 |
| 68 | Abnormality of renin-angiotensin system (HP:0000847) | 2.53734922 |
| 69 | Abnormality of nucleobase metabolism (HP:0010932) | 2.53494456 |
| 70 | Skin nodule (HP:0200036) | 2.52742360 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.51946954 |
| 72 | Steatorrhea (HP:0002570) | 2.51254419 |
| 73 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.49063304 |
| 74 | Papilledema (HP:0001085) | 2.45204008 |
| 75 | Widely patent fontanelles and sutures (HP:0004492) | 2.43778442 |
| 76 | Colitis (HP:0002583) | 2.43622121 |
| 77 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.43542574 |
| 78 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.43542574 |
| 79 | Metabolic alkalosis (HP:0200114) | 2.43243928 |
| 80 | Myocardial infarction (HP:0001658) | 2.40612212 |
| 81 | Orchitis (HP:0100796) | 2.38444639 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.37422247 |
| 83 | Pustule (HP:0200039) | 2.36047758 |
| 84 | Right ventricular cardiomyopathy (HP:0011663) | 2.34930114 |
| 85 | Inflammation of the large intestine (HP:0002037) | 2.32014286 |
| 86 | Pili torti (HP:0003777) | 2.28450963 |
| 87 | Poikilocytosis (HP:0004447) | 2.27441173 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.25264139 |
| 89 | Spontaneous abortion (HP:0005268) | 2.24872874 |
| 90 | Abnormal tarsal ossification (HP:0008369) | 2.24466640 |
| 91 | Pancreatitis (HP:0001733) | 2.24226397 |
| 92 | Irritability (HP:0000737) | 2.23291796 |
| 93 | Ankle clonus (HP:0011448) | 2.20727910 |
| 94 | Cellulitis (HP:0100658) | 2.17266566 |
| 95 | Gout (HP:0001997) | 2.14856743 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 2.14608744 |
| 97 | Chronic diarrhea (HP:0002028) | 2.14542096 |
| 98 | Gastrointestinal infarctions (HP:0005244) | 2.14348557 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13247926 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 2.13247926 |
| 101 | Generalized aminoaciduria (HP:0002909) | 2.09744471 |
| 102 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09733101 |
| 103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.06920135 |
| 104 | Abnormal gallbladder physiology (HP:0012438) | 2.05702634 |
| 105 | Cholecystitis (HP:0001082) | 2.05702634 |
| 106 | Abnormal gallbladder morphology (HP:0012437) | 2.05514209 |
| 107 | Alkalosis (HP:0001948) | 2.04538028 |
| 108 | Esophageal varix (HP:0002040) | 2.03680148 |
| 109 | Axonal loss (HP:0003447) | 2.03401280 |
| 110 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.03275296 |
| 111 | Prolonged bleeding time (HP:0003010) | 1.99231490 |
| 112 | Polycythemia (HP:0001901) | 1.98987843 |
| 113 | Glycosuria (HP:0003076) | 1.97684546 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 1.97684546 |
| 115 | Meningitis (HP:0001287) | 1.96428331 |
| 116 | Acute hepatic failure (HP:0006554) | 1.96019541 |
| 117 | Recurrent fungal infections (HP:0002841) | 1.94482911 |
| 118 | Vasculitis (HP:0002633) | 1.92398712 |
| 119 | Polygenic inheritance (HP:0010982) | 1.92233399 |
| 120 | Seborrheic dermatitis (HP:0001051) | 1.91796635 |
| 121 | Gastrointestinal dysmotility (HP:0002579) | 1.90479008 |
| 122 | Nephrolithiasis (HP:0000787) | 1.90413952 |
| 123 | Cholelithiasis (HP:0001081) | 1.90112145 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.89943801 |
| 125 | Visceral angiomatosis (HP:0100761) | 1.89926314 |
| 126 | Broad face (HP:0000283) | 1.89735601 |
| 127 | Protuberant abdomen (HP:0001538) | 1.89175234 |
| 128 | Optic neuritis (HP:0100653) | 1.88678250 |
| 129 | Retrobulbar optic neuritis (HP:0100654) | 1.88678250 |
| 130 | Gingival bleeding (HP:0000225) | 1.88578982 |
| 131 | Pigmentary retinal degeneration (HP:0001146) | 1.87928477 |
| 132 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87370497 |
| 133 | Onion bulb formation (HP:0003383) | 1.86810267 |
| 134 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86674659 |
| 135 | Ventricular fibrillation (HP:0001663) | 1.86026529 |
| 136 | Vascular calcification (HP:0004934) | 1.85296481 |
| 137 | Hyperparathyroidism (HP:0000843) | 1.84928207 |
| 138 | Amyloidosis (HP:0011034) | 1.84376832 |
| 139 | Menorrhagia (HP:0000132) | 1.84020398 |
| 140 | Delayed CNS myelination (HP:0002188) | 1.83380049 |
| 141 | Hypertriglyceridemia (HP:0002155) | 1.83341028 |
| 142 | Glomerulonephritis (HP:0000099) | 1.83229381 |
| 143 | Lethargy (HP:0001254) | 1.82313833 |
| 144 | Alveolar cell carcinoma (HP:0006519) | 1.81652372 |
| 145 | Abnormality of chloride homeostasis (HP:0011422) | 1.81544193 |
| 146 | Nephritis (HP:0000123) | 1.81018440 |
| 147 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.80784620 |
| 148 | Insulin resistance (HP:0000855) | 1.79439973 |
| 149 | Obstructive lung disease (HP:0006536) | 1.79209874 |
| 150 | Chronic obstructive pulmonary disease (HP:0006510) | 1.79209874 |
| 151 | Recurrent skin infections (HP:0001581) | 1.79135804 |
| 152 | Bone pain (HP:0002653) | 1.78594914 |
| 153 | Mucopolysacchariduria (HP:0008155) | 1.78426894 |
| 154 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78426894 |
| 155 | Autoimmune hemolytic anemia (HP:0001890) | 1.78110072 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77887451 |
| 157 | Osteomyelitis (HP:0002754) | 1.77193326 |
| 158 | Spastic diplegia (HP:0001264) | 1.76876473 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.76843230 |
| 160 | Papilloma (HP:0012740) | 1.76514124 |
| 161 | Verrucae (HP:0200043) | 1.76514124 |
| 162 | Slow saccadic eye movements (HP:0000514) | 1.76471118 |
| 163 | Increased mean platelet volume (HP:0011877) | 1.76227569 |
| 164 | Urticaria (HP:0001025) | 1.75057486 |
| 165 | Premature loss of primary teeth (HP:0006323) | 1.73636890 |
| 166 | Increased cerebral lipofuscin (HP:0011813) | 1.72693477 |
| 167 | Wide cranial sutures (HP:0010537) | 1.72667347 |
| 168 | Hypophosphatemia (HP:0002148) | 1.72120573 |
| 169 | Gastrointestinal stroma tumor (HP:0100723) | 1.71958685 |
| 170 | Mediastinal lymphadenopathy (HP:0100721) | 1.70066628 |
| 171 | Hemoptysis (HP:0002105) | 1.69175320 |
| 172 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69038671 |
| 173 | Abnormal hair laboratory examination (HP:0003328) | 1.67758244 |
| 174 | Dysostosis multiplex (HP:0000943) | 1.67587436 |
| 175 | Stomatitis (HP:0010280) | 1.67308560 |
| 176 | Pulmonary infiltrates (HP:0002113) | 1.67126442 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.63846768 |
| 2 | ERN1 | 3.78047847 |
| 3 | RIPK4 | 3.46614041 |
| 4 | INSRR | 3.40025720 |
| 5 | PRPF4B | 3.24530754 |
| 6 | TAOK3 | 3.02508212 |
| 7 | FGFR4 | 2.92511946 |
| 8 | MST1R | 2.68923131 |
| 9 | BCKDK | 2.62878434 |
| 10 | SIK1 | 2.59354732 |
| 11 | MAP3K2 | 2.33370146 |
| 12 | GRK6 | 2.31313879 |
| 13 | LMTK2 | 2.20193683 |
| 14 | PTK6 | 2.08877703 |
| 15 | RIPK1 | 1.95085519 |
| 16 | PKN2 | 1.90636244 |
| 17 | FLT3 | 1.88816756 |
| 18 | TRIB3 | 1.73423882 |
| 19 | MAP3K10 | 1.70264371 |
| 20 | TNK2 | 1.69081825 |
| 21 | PRKG2 | 1.59790575 |
| 22 | MAP2K2 | 1.47471565 |
| 23 | MAP3K13 | 1.42258847 |
| 24 | SMG1 | 1.38869682 |
| 25 | MAP3K7 | 1.38240880 |
| 26 | MST4 | 1.33588283 |
| 27 | MAP3K1 | 1.30227435 |
| 28 | TYK2 | 1.28971547 |
| 29 | KSR2 | 1.23076282 |
| 30 | BLK | 1.22036793 |
| 31 | MAP3K11 | 1.21207311 |
| 32 | PIK3CA | 1.20493808 |
| 33 | TAOK1 | 1.18984232 |
| 34 | FES | 1.18560094 |
| 35 | PTK2 | 1.18461580 |
| 36 | FGFR3 | 1.13878800 |
| 37 | JAK2 | 1.13666569 |
| 38 | JAK1 | 1.13556167 |
| 39 | MAP4K1 | 1.13523313 |
| 40 | IRAK4 | 1.13500548 |
| 41 | TBK1 | 1.13160233 |
| 42 | DAPK2 | 1.11166558 |
| 43 | PIK3CG | 1.08470382 |
| 44 | MET | 1.05594939 |
| 45 | TESK2 | 1.02585579 |
| 46 | CDK12 | 1.02413732 |
| 47 | MAPK11 | 1.01729339 |
| 48 | AKT3 | 1.00406963 |
| 49 | ITK | 1.00276157 |
| 50 | PRKAA2 | 0.99792294 |
| 51 | IKBKE | 0.98643556 |
| 52 | SIK3 | 0.96375533 |
| 53 | BTK | 0.95868235 |
| 54 | PDGFRA | 0.93850318 |
| 55 | ACVR1B | 0.92750227 |
| 56 | EPHB1 | 0.92603461 |
| 57 | MAPK12 | 0.90229443 |
| 58 | ICK | 0.89504321 |
| 59 | STK38 | 0.88510989 |
| 60 | PDPK1 | 0.88340496 |
| 61 | EPHA3 | 0.85774023 |
| 62 | JAK3 | 0.85591726 |
| 63 | MAPK15 | 0.84936126 |
| 64 | PDK1 | 0.84741687 |
| 65 | TESK1 | 0.84054151 |
| 66 | HCK | 0.83781708 |
| 67 | MAP2K4 | 0.83280126 |
| 68 | LATS1 | 0.82562776 |
| 69 | HIPK2 | 0.81821819 |
| 70 | RET | 0.81660940 |
| 71 | GRK5 | 0.79941913 |
| 72 | NUAK1 | 0.78724359 |
| 73 | PRKCH | 0.77779573 |
| 74 | LRRK2 | 0.77243097 |
| 75 | DYRK1B | 0.76536698 |
| 76 | NLK | 0.75578577 |
| 77 | MAPK7 | 0.75065485 |
| 78 | ZAP70 | 0.74896482 |
| 79 | SGK3 | 0.74720970 |
| 80 | CSK | 0.74493462 |
| 81 | PASK | 0.72938802 |
| 82 | MAP3K3 | 0.71728899 |
| 83 | ERBB2 | 0.71643016 |
| 84 | MAP2K6 | 0.69984641 |
| 85 | MAP3K9 | 0.68846855 |
| 86 | PRKAA1 | 0.68591893 |
| 87 | TGFBR2 | 0.68390107 |
| 88 | EPHA2 | 0.67718849 |
| 89 | EPHA4 | 0.65992476 |
| 90 | FGFR2 | 0.65521134 |
| 91 | RPS6KA2 | 0.65173542 |
| 92 | YES1 | 0.64930086 |
| 93 | MAP3K6 | 0.64034660 |
| 94 | NEK6 | 0.63758752 |
| 95 | IRAK2 | 0.63515826 |
| 96 | CAMKK1 | 0.61905736 |
| 97 | LCK | 0.59336432 |
| 98 | MAPKAPK3 | 0.58496244 |
| 99 | PRKCQ | 0.58420473 |
| 100 | BMPR2 | 0.58364283 |
| 101 | NTRK1 | 0.57506690 |
| 102 | PAK3 | 0.57179606 |
| 103 | SYK | 0.56710715 |
| 104 | SCYL2 | 0.56267771 |
| 105 | FYN | 0.56178635 |
| 106 | NME1 | 0.56000038 |
| 107 | MAP3K14 | 0.54864033 |
| 108 | ERBB4 | 0.53934125 |
| 109 | FER | 0.52272654 |
| 110 | MATK | 0.51610285 |
| 111 | MAP2K1 | 0.51424121 |
| 112 | CAMKK2 | 0.51323768 |
| 113 | EEF2K | 0.50982543 |
| 114 | SIK2 | 0.50482071 |
| 115 | IRAK1 | 0.50300313 |
| 116 | PRKACG | 0.49313490 |
| 117 | PAK4 | 0.48498541 |
| 118 | FGR | 0.47324518 |
| 119 | ARAF | 0.47148813 |
| 120 | PRKD3 | 0.46440545 |
| 121 | STK10 | 0.46074151 |
| 122 | CSF1R | 0.45770953 |
| 123 | TXK | 0.44708790 |
| 124 | LYN | 0.43491241 |
| 125 | PDGFRB | 0.42660591 |
| 126 | TAOK2 | 0.41390436 |
| 127 | CAMK1D | 0.40411753 |
| 128 | STK11 | 0.40097553 |
| 129 | CAMK2G | 0.38525483 |
| 130 | PRKCZ | 0.37751730 |
| 131 | TYRO3 | 0.37529221 |
| 132 | PRKCA | 0.35013908 |
| 133 | IRAK3 | 0.32878350 |
| 134 | MAP2K3 | 0.32424227 |
| 135 | PRKD2 | 0.32380995 |
| 136 | IGF1R | 0.32212233 |
| 137 | CDC42BPA | 0.31409092 |
| 138 | PRKCI | 0.30880771 |
| 139 | MARK2 | 0.30623267 |
| 140 | GSK3A | 0.30551896 |
| 141 | PRKD1 | 0.30508230 |
| 142 | KDR | 0.28538138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35253245 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33749104 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.13409583 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12850007 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.04188226 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.78016675 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.65257714 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54301901 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.32796260 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.14058293 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13234899 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.09123265 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05200815 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.97165726 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95855360 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.92949345 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.85445467 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83554871 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.77851837 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.75921652 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71635360 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.69467606 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67687949 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56791607 |
| 25 | ABC transporters_Homo sapiens_hsa02010 | 1.55141839 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54935171 |
| 27 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.52244486 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.46179649 |
| 29 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.43923089 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.43030652 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41113027 |
| 32 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39783232 |
| 33 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36460627 |
| 34 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35917649 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35285204 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34486151 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33114211 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.31853379 |
| 39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30209267 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.26113500 |
| 41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24960851 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24233494 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.24115580 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.22825576 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.22813441 |
| 46 | Mineral absorption_Homo sapiens_hsa04978 | 1.21528736 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.20016285 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18336395 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17362157 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.16435669 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15842790 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.10510534 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10471001 |
| 54 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09145535 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.08676862 |
| 56 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07235614 |
| 57 | Allograft rejection_Homo sapiens_hsa05330 | 1.06512620 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.06189921 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04446605 |
| 60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02160311 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01807529 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00737132 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99408269 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.97396249 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96801703 |
| 66 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94541555 |
| 67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91286736 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89746931 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88631862 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.87549791 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87524918 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86447080 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86353959 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85964698 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.83990338 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83009013 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82853630 |
| 78 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.82590244 |
| 79 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.81095149 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.79532493 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78303781 |
| 82 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77333536 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77031670 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.76272511 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74928225 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.73657745 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.72237044 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72086351 |
| 89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71127111 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.69691997 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69473755 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68727214 |
| 93 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68514265 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.68338527 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66873087 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66708453 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65555425 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.65189592 |
| 99 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.64670765 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.64570496 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.64535251 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63712275 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62093627 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.62032092 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60723847 |
| 106 | Insulin resistance_Homo sapiens_hsa04931 | 0.60522891 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60204940 |
| 108 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59615383 |
| 109 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59269133 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.58623699 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56005301 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.55559596 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54324414 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53339123 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53166347 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52827499 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52723075 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51933931 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.51891500 |
| 120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51100636 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50628427 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50476264 |
| 123 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.49742366 |
| 124 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49454114 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49159024 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47268321 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46983641 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45361222 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42445620 |
| 130 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39347491 |
| 131 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38925674 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37429398 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37015836 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36704120 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34605922 |
| 136 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.33940204 |
| 137 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33250520 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31406014 |
| 139 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28263024 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26328940 |
| 141 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22436956 |
| 142 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.20569411 |
| 143 | Prion diseases_Homo sapiens_hsa05020 | 0.19756157 |
| 144 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.17192883 |
| 145 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14392651 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.14019865 |
| 147 | Cocaine addiction_Homo sapiens_hsa05030 | 0.11351534 |
| 148 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09342849 |
| 149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.07005316 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.04663568 |
| 151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.04637061 |
| 152 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.04339126 |
| 153 | Salivary secretion_Homo sapiens_hsa04970 | 0.04120567 |
| 154 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.00864497 |

